| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/19/2012 | US20120183589 Lipid Nanoparticles For Gene Therapy |
| 07/19/2012 | US20120183551 Novel human p53 splice variant displaying differential transcriptional activity |
| 07/19/2012 | US20120183524 Molecular targets for treatment of inflammation |
| 07/19/2012 | US20120183523 Methods and Compounds for Promoting Vessel Regression |
| 07/19/2012 | US20120183502 Combination therapy for lysosomal storage diseases |
| 07/18/2012 | EP2476756A1 Amine-containing lipids and uses thereof |
| 07/18/2012 | EP2476751A1 Cardiac muscle regeneration using mesenchymal stem cells |
| 07/18/2012 | EP2475779A1 Detecting pax2 for the diagnosis of breast cancer |
| 07/18/2012 | EP2475367A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 07/18/2012 | EP1542701B1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 07/18/2012 | EP1470148B1 Double-stranded oligonucleotides |
| 07/18/2012 | EP1389909B1 Antimicrobial compounds and methods for their use |
| 07/18/2012 | CN1946734B Compositions and methods for the systemic treatment of arthritis |
| 07/18/2012 | CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use |
| 07/18/2012 | CN102597238A Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2 |
| 07/18/2012 | CN102597236A ERCC6L as target genes for cancer therapy and diagnosis |
| 07/18/2012 | CN102596256A Composition for treatment of pancreatic cancer |
| 07/18/2012 | CN102596255A Gene vector |
| 07/18/2012 | CN102586437A Application of CCDC72 gene and its expression product in preparing preparation for diagnosing and treating ovarian cancer |
| 07/18/2012 | CN102586407A Application of synuclein gamma (SNCG) gene in diagnosis and hormone therapy of breast cancer |
| 07/18/2012 | CN102586327A D24 fiber protein modified conditionally replicating adenovirus carrier with exogenous gene by one-step method and application of carrier |
| 07/18/2012 | CN102586324A Construction method of cell for gene therapy and obtained cell |
| 07/18/2012 | CN102586300A Polyamide amine, part degradation product or complex of polyamide amine-Math1 gene nano microparticles and application of gene nano microparticles in treating deafness |
| 07/18/2012 | CN102586276A 通过操作信使rna前体加工而提供的针对环境毒性的保护 By operating messenger rna precursor processing and provides protection against environmental toxicity |
| 07/18/2012 | CN102586237A Poly-nucleic acid molecule and application thereof |
| 07/18/2012 | CN102586198A Recombinant adenovirus capable of resisting foot and mouth disease virus replication and infection as well as preparation method and application of recombinant adenovirus |
| 07/18/2012 | CN102586174A Pluripotent cell derived from cataract mouse model, its preparation method and application |
| 07/18/2012 | CN102586129A Oil producing rhodococcus sp.RHA-MLDS having MLDS (Multiple Low Dose Streptozotocin) gene knocked out and purpose of oil producing rhodococcus sp.RHA-MLDS |
| 07/18/2012 | CN102585151A Polyurethane segmented copolymer containing disulfide bonds and tertiary amine groups as well as preparation method of polyurethane segmented copolymer |
| 07/18/2012 | CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 07/18/2012 | CN102584986A Application of neuroglobin to promotion of neurite growth |
| 07/18/2012 | CN102580118A Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine |
| 07/18/2012 | CN102580117A Application of miRNA-122 restraining agent to preparation of medicament for treating congenital heart disease |
| 07/18/2012 | CN102580116A Duck virus hepatitis suicide DNA vaccine, as well as constructing method and application thereof |
| 07/18/2012 | CN102580115A Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine |
| 07/18/2012 | CN102580114A Novel applications of novel potential anti-cancer gene CMTM7 and encoding protein thereof |
| 07/18/2012 | CN102579357A Magnet composite drug-carrying microspheres and preparation method thereof |
| 07/18/2012 | CN102578039A Zebrafish liver replication model for human HCV (hepatitis C virus) genes |
| 07/18/2012 | CN102041270B Construction and screening of siRNAs (small interfering RANs) expression vectors of gastric cancer targeted DEC1 (differentiated embryo-chondrocyte expressed gene 1) and application thereof |
| 07/18/2012 | CN102021160B Snake venom serine protease and coding gene and application thereof |
| 07/18/2012 | CN101979581B S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof |
| 07/18/2012 | CN101875693B Albumin variant having anti-angiogenesis activity and preparation method thereof |
| 07/18/2012 | CN101851625B RNA interference sequences of glucagon receptor gene |
| 07/18/2012 | CN101831427B Oligodeoxyribonudeotide for preventing recurrence of tumor and inhibiting tumor growth as well as application thereof |
| 07/18/2012 | CN101792743B Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof |
| 07/18/2012 | CN101711862B Medicine target spot relevant to inflammatory diseases and application thereof |
| 07/18/2012 | CN101068574B Specific inhibition of autoimmunity and diseases associated with autoantigens |
| 07/17/2012 | US8222480 Hypertonic conditions for cell and oocyte enucleation |
| 07/17/2012 | US8222398 Chimeric immunomodulatory compounds and methods of using the same-II |
| 07/17/2012 | US8222394 MicroRNA molecules |
| 07/17/2012 | US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders |
| 07/17/2012 | US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids |
| 07/17/2012 | US8222384 Modified and stabilized GDF propeptides and uses thereof |
| 07/17/2012 | US8222225 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 07/17/2012 | US8222224 Chimeric adenoviral vectors |
| 07/17/2012 | US8222223 Method of treating biocells |
| 07/17/2012 | US8222220 Nanogenomics for medicine: siRNA engineering |
| 07/17/2012 | US8222029 Lentiviral vector-based vaccine |
| 07/17/2012 | US8222002 Human anti-amyloid beta peptide antibody and fragment of said antibody |
| 07/17/2012 | US8221971 Altering human immune response to adenoviral vector via modification of capsid proteins; improved exogenous gene expression |
| 07/17/2012 | US8221769 Microorganisms for therapy |
| 07/17/2012 | US8221768 Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence |
| 07/17/2012 | US8221759 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/17/2012 | US8221757 Monoclonal antibodies against extracellular loops of C5aR |
| 07/17/2012 | US8221748 Compositions and methods for the systemic treatment of arthritis |
| 07/17/2012 | US8221740 Side population cells in cardiac repair |
| 07/17/2012 | US8221739 Method of cancer treatment |
| 07/17/2012 | CA2488366C Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/17/2012 | CA2462455C Development of a preventive vaccine for filovirus infection in primates |
| 07/17/2012 | CA2446955C A device for forming or increasing the number of undifferentiated cells |
| 07/17/2012 | CA2446201C Improved neuronal gene transfer |
| 07/17/2012 | CA2410948C Method for the purification of alphavirus replicon particles |
| 07/17/2012 | CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof |
| 07/17/2012 | CA2322559C Compositions and methods for modulating vascularization |
| 07/17/2012 | CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 07/12/2012 | WO2012094681A1 Compositions and methods for the diagnosis of schizophrenia |
| 07/12/2012 | WO2012094574A2 Stabilized polyribonucleotide nanoparticles |
| 07/12/2012 | WO2012094560A2 Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases |
| 07/12/2012 | WO2012094512A2 Myocardial tissue targeting peptides |
| 07/12/2012 | WO2012094511A2 Compositions and methods for the treatment of orthopedic disease or injury |
| 07/12/2012 | WO2012094193A2 Methods for enhancing the delivery of gene-transduced cells |
| 07/12/2012 | WO2012094081A2 System and method for identifying and applying peripheral treatment mechanisms for disease |
| 07/12/2012 | WO2012092865A1 Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers |
| 07/12/2012 | WO2012092849A1 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 07/12/2012 | WO2012092645A1 Novel antisense oligonucleotides |
| 07/12/2012 | WO2012068405A3 Modulation of alpha synuclein expression |
| 07/12/2012 | WO2012068340A3 Antagonat compositions and methods of use |
| 07/12/2012 | WO2012058241A3 Methods and compositions for ameliorating pancreatic cancer |
| 07/12/2012 | WO2012052872A9 Methods and compositions for the treatment of insulin-associated medical conditions |
| 07/12/2012 | WO2012009508A3 Microrna compositions and methods related thereto |
| 07/12/2012 | US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production |
| 07/12/2012 | US20120178698 Agents and Uses Thereof |
| 07/12/2012 | US20120177672 Therapeutic peptides, polypeptides and nucleic acid sequences |
| 07/12/2012 | US20120177605 Delivery of Polynucleotides Across the Blood-Brain-Barrier Using Recombinant AAV9 |
| 07/12/2012 | US20120177573 Methods for conjugating nucleic acids with small molecules |
| 07/12/2012 | CA2824643A1 Methods for enhancing the delivery of gene-transduced cells |
| 07/12/2012 | CA2823890A1 Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases |
| 07/11/2012 | EP2474611A1 Enhancer for promoter, and use thereof |
| 07/11/2012 | EP2474325A1 Drug composition for angiogenesis therapy |
| 07/11/2012 | EP2474315A1 Immunity inducer |